AJANTPHARM.NS Ajanta Pharmaceuticals Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 39913 | 20939 | 52.46% |
| 2026-08-27 | 49671 | 30575 | 61.56% |
| 2026-08-26 | 35227 | 19640 | 55.75% |
| 2026-08-25 | 116770 | 69028 | 59.11% |
| 2026-08-24 | 65679 | 35038 | 53.35% |
| 2026-08-21 | 51825 | 24938 | 48.12% |
| 2026-08-20 | 69455 | 25325 | 36.46% |
| 2026-08-19 | 84540 | 24428 | 28.90% |
| 2026-08-18 | 145440 | 73196 | 50.33% |
| 2026-08-17 | 110437 | 57879 | 52.41% |
| 2026-08-14 | 95494 | 49429 | 51.76% |
| 2026-08-13 | 136792 | 55218 | 40.37% |
| 2026-08-12 | 82946 | 45490 | 54.84% |
| 2026-08-11 | 86524 | 41275 | 47.70% |
| 2026-08-10 | 43409 | 21047 | 48.49% |
| 2026-08-07 | 34852 | 19449 | 55.80% |
| 2026-08-06 | 49287 | 25907 | 52.56% |
| 2026-08-05 | 126648 | 58288 | 46.02% |
| 2026-08-04 | 83877 | 42331 | 50.47% |
| 2026-08-03 | 119278 | 65832 | 55.19% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers AJANTPHARM.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 13 Mar 2026 | SHAILESH R SINGH | Other | Sell | Market Sale | 607 | 1881809 | 0.01% | XBRL |
| 29 Dec 2025 | SHAILESH R SINGH | Other | Sell | Market Sale | 750 | 2034810 | 0.01% | XBRL |
| 13 Nov 2025 | SHAILESH R SINGH | Other | Sell | Market Sale | 3000 | 7585290 | 0.01% | XBRL |
| 13 Nov 2025 | SHAILESH R SINGH | Other | Sell | Market Sale | 2000 | 5130820 | 0.01% | XBRL |
| 26 Jun 2025 | SHAILESH R SINGH | Other | Sell | Market Sale | 900 | 2316987 | 0.02% | XBRL |
| 28 Feb 2025 | VANDANA SHAILESH SINGH | Other | Sell | Market Sale | 548 | 1491902 | 0.00% | XBRL |
| 31 Dec 2024 | J K TRIPATHI | Other | Sell | Market Sale | 51 | 158100 | 0.00% | XBRL |
| 31 Dec 2024 | J K TRIPATHI | Other | Sell | Market Sale | 49 | 149940 | 0.00% | XBRL |
| 31 Dec 2024 | J K TRIPATHI | Other | Sell | Market Sale | 100 | 300000 | 0.00% | XBRL |
| 31 Dec 2024 | J K TRIPATHI | Other | Sell | Market Sale | 100 | 289500 | 0.00% | XBRL |
| 31 Dec 2024 | J K TRIPATHI | Other | Sell | Market Sale | 100 | 295000 | 0.00% | XBRL |
| 06 Sep 2024 | ARVIND K AGRAWAL | Other | Buy | ESOP | 1000 | 2000 | 0.02% | XBRL |
| 06 Sep 2024 | SEEMA AGRAWAL | Immediate relative | Sell | Market Sale | 5000 | 16436150 | 0.02% | XBRL |
| 06 Sep 2024 | ARVIND K AGRAWAL | Other | Sell | Market Sale | 6000 | 19761720 | 0.01% | XBRL |
| 04 Sep 2024 | J K TRIPATHI | Other | Sell | Market Sale | 200 | 561706 | 0.00% | XBRL |
| 04 Sep 2024 | J K TRIPATHI | Other | Buy | ESOP | 500 | 1000 | 0.00% | XBRL |
| 04 Sep 2024 | J K TRIPATHI | Other | Sell | Market Sale | 100 | 299103 | 0.00% | XBRL |
| 04 Sep 2024 | J K TRIPATHI | Other | Sell | Market Sale | 100 | 320000 | 0.00% | XBRL |
| 16 Aug 2024 | AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUST | Promoters | Pledge | Revokation of Pledge | 17 | 53993 | 11.30% | XBRL |
| 16 Aug 2024 | AAYUSH M AGRAWAL, TRUSTEE AAYUSH AGRAWAL TRUST | Promoters | Pledge | Revokation of Pledge | 169983 | 539883006 | 11.30% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers AJANTPHARM.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,054.08 Cr. | ₹1,144.92 Cr. | ₹1,186.64 Cr. | ₹1,146.13 Cr. | ₹1,170.41 Cr. | ₹1,302.65 Cr. | ₹1,353.73 Cr. | ₹1,374.84 Cr. | ₹1,421.64 Cr. | ₹1,625.96 Cr. | RevenueFromOperations |
| Net Profit | ₹196.33 Cr. incl. minority ₹202.72 Cr. | ₹238.43 Cr. incl. minority ₹245.77 Cr. | ₹216.48 Cr. | ₹232.88 Cr. | ₹225.26 Cr. | ₹255.34 Cr. | ₹260.19 Cr. | ₹273.77 Cr. | ₹266.70 Cr. | ₹329.96 Cr. incl. minority ₹334.22 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers AJANTPHARM.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 10560000000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 125350000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 37354300000.0 |
| CurrentLiabilities | 14157500000.0 |
| EquityAttributableToOwnersOfParent | 45270900000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 2119900000.0 |